Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Paclitaxel therapeutic drug monitoring - International association of therapeutic drug monitoring and clinical toxicology recommendations

European Journal of Cancer(2024)10.1016/j.ejca.2024.114024Source: DataRank Database

Paclitaxel therapeutic drug monitoring - International association of therapeutic drug monitoring and clinical toxicology recommendations is a research paper published in European Journal of Cancer (2024). On theSindex it has a DataRank of 0. It has been cited 26 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access26 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 4.90)OA: bronzeTopics (37)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Markus Joerger ORCID,Yung‐Jue Bang ORCID,Ron H.J. Mathijssen ORCID,Caicun Zhou ORCID,Li Zhang ORCID

Live enrichment

PubMed:38513383 PMC:PMC11053297 OpenAlex:https://openalex.org/W4392962087

NCI NIH HHS

Grant: P30 CA047904

NCI NIH HHS

Grant: U24 CA247643

NCI NIH HHS

Grant: UM1 CA186690

National Cancer Institute

FWCI

4.90

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

bronzeLicense: http://creativecommons.org/licenses/by-nc/4.0/

journalhttp://www.ejcancer.com/article/S0959804924006804/pdf

publisherhttp://www.ejcancer.com/article/S0959804924006804/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0959804924006804?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0959804924006804?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ejca.2024.114024

Fields of Study

Cancer Treatment and PharmacologyLung Cancer Treatments and MutationsNeutropenia and Cancer InfectionsHumansPaclitaxelCarcinoma, Non-Small-Cell LungDrug MonitoringRetrospective StudiesProspective StudiesLung Neoplasms

MeSH Terms

Carcinoma, Non-Small-Cell LungHumansLung NeoplasmsProspective StudiesRetrospective StudiesDrug MonitoringPaclitaxel

Keywords

PaclitaxelDosingMedicineTherapeutic drug monitoringDrugToxicityClinical trialPharmacologyEfficacyOncologyChemotherapyInternal medicineIntensive care medicineExposureResponseTDMClinical BenefitPlasma ConcentrationsDose AdjustmentTime Above Threshold